OIL TO POWDER
LIVE

Serial Number

90044403

Owner

OROCAN AG

Attorney

Shoko Naruo

Filing Date

Jul 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OIL TO POWDER Trademark

Serial Number: 90044403 • Registration: 7370019

OIL TO POWDER is a trademark filed by OROCAN AG on July 9, 2020. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

OROCAN AG (6 trademarks)

Kraftwerkstrasse 6

Entity Type: 24

Trademark Details

Filing Date

July 9, 2020

Registration Date

April 30, 2024

Published for Opposition

February 13, 2024

Goods & Services

Flowers and leaves as tea substitutes; preparations for making tea-based beverages; non medicinal herb teas; Flavorings for food, except essential essences and oils; food flavorings, except essential oils; food stuffs comprised of hemp, namely, chocolates, candy, granola based snack foods, coffee based snack foods, rice based snack foods, snack cakes, cookies, brownies, corn based snack foods, granola snacks, corn based snack foods; cereal preparations, namely, cereal bars, high protein cereal bars, cereal based energy bars, breakfast cereals, cereal based snack foods, processed cereal flakes; processed seeds used as spices; processed hemp in the nature of dried herbs, dried herbs in powdered form; Chemicals for use in foods for culinary purposes, namely, cream of tartar or gluten; none of the foregoing items containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis and none comprised of cannabidiol (CBD) above a naturally occurring trace amount

Chemical food supplements; Pharmaceutical preparations for use in the treatment of pain, nausea, insomnia, PTSD, cancer, seizures, anxiety, diabetes, colds and flu, muscle and joint pain, arthritis, antiviral inflammatory diseases, Covid 19; medical preparations for use in the treatment of pain, nausea, insomnia, PTSD, cancer, seizures, anxiety, diabetes, colds and flu, muscle and joint pain, arthritis, skin rashes, Covid 19, inflammatory diseases; veterinary preparations for use in the treatment of pain, nausea, seizures, anxiety, muscle and joint pain, arthritis, skin rashes, antiviral inflammatory diseases, Covid 19; food supplements for human and veterinary use; medicinal products and natural remedies, namely, cough syrup, topical analgesics, medicated skin creams, natural remedies in the nature of herbal tinctures for medicinal use, medications for the treatment of muscles and joint pain, seizures, insomnia, nausea, antiviral inflammatory diseases, Covid 19; extracts made of medicinal plants for pharmaceutical and medicinal use; dietetic preparations specially adapted for medical use; food supplements; antioxidants in the nature of a food supplement; dietetic foodstuffs and preparations for medical or veterinary use; food supplements for humans; food supplements for animals; cannabis for medical purposes, namely, in the nature of medicinal herbs, in the nature of a medicinal herbal extract, topical analgesics, medicated skin and body lotions, creams, gels and balms, cannabis based pills, capsules, tinctures and liquids for use in treating pain, nausea, insomnia, PTSD, cancer, seizures, eating disorders; hemp extracts for pharmaceutical purposes; plasters, namely, medical plasters, surgical plasters, corn plasters, adhesive plasters for medical purposes, gummed taffeta plasters; materials for dressings, namely, medical and surgical dressings, bandages for skin wounds, surgical bandages, antiseptic liquid bandages, bandages impregnated with medicinal cannabis extracts; processed hemp, namely, hemp protein dietary supplements, hemp protein supplement shakes, hemp seed oil dietary supplement preparations; none of the foregoing items containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis and none comprised of cannabidiol (CBD) above a naturally occurring trace amount

Preparations for body and beauty care for personal use, namely, cosmetic skin and body lotions, creams and gels, cosmetic bath soaps, hair shampoos and conditioners, non-medicated lip balms, facial cosmetics, deodorants for personal use, deodorant soap, cosmetic skin peels, antioxidants sold as a component of cosmetics; perfumery; essential oils; ointments for cosmetic purposes; herbal aromatic essences in the nature of essential oils; essential oils for aroma therapy; oils for cosmetic purposes; essential oils for personal use; essential oils and aromatic extracts comprised of essential oils; essential oils for calming down the nerves; essential essences and oils; herbal extracts for cosmetic purposes; phytocosmetic preparations; hair lotions; bath salts, not for medical use; dentifrices; non-medicated dental and mouth care preparations; cannabis for cosmetic purposes, namely, cannabis based bath soaps, skin lotions and moisturizers, bath lotions, hair shampoos and conditions, skin toners and skin cleansers, cosmetic skin peels, and antioxidants sold as a component of cosmetics; none of the foregoing containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis; hemp extracts sold as a component of cosmetics, aroma preparations in the nature of essential oils for the preparation of non-medicated herbal teas, substances used as flavoring agents for food stuffs in the nature of essential oils; aroma preparations in the nature of essential oils use in the preparation of non-medicated infusions for foods and beverages; none of the foregoing containing hemp with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis, and none comprised of cannabidiol (CBD) above a naturally occurring trace amount

Cannabis extracts for use in the manufacture of foods; cannabis extracts for the manufacture of cosmetics; cannabis extracts for the manufacture of pharmaceutical preparations; proteins for the food industry; proteins for the manufacture of food supplements; herbal extracts, except essential oils, for the manufacture of cosmetics; plant extracts, except essential oils, for manufacture of cosmetics; biological preparations for use in industry and science; antioxidants for the manufacture of cosmetics; antioxidants for the manufacture of food supplements; antioxidants for the manufacture of food and beverages; antioxidants for the manufacture of pharmaceutical preparations; chemical preparations used in industry; chemical preparations used in the manufacture of foods; chemical preserving agents for foodstuffs; chemicals used as food additives in the manufacture of foods; plant extracts for the manufacture of pharmaceutical preparations; plant extracts for the manufacture of cosmetics; extracts made of medicinal plants for use in the manufacture of foods, beverages, dietary supplements, pharmaceuticals; antioxidants for use in the manufacture of foods, beverages, cosmetics, dietary supplements, pharmaceuticals; processed hemp, namely, hemp protein for use in manufacturing foods, beverages, cosmetics, pharmaceuticals; none of the foregoing items containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis, and none comprised of cannabidiol (CBD) above a naturally occurring trace amount

Quality control of pharmaceuticals, medicinal and cosmetic preparations as well as for food products; Evaluation, testing and analysis of pharmaceutical, medicinal and cosmetic preparations as well as of food products to assure compliance with industry standards; Certification in the nature of testing, evaluation and analysis of the goods of others to determine conformity with certification standards; quality control of raw materials; none of the foregoing services involving the possession or dissemination of goods containing hemp with a delta-9 tetrahydrocannabinol THC concentration of more than 0.3 percent on a dry weight basis

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 22, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 22, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 19, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 28, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 6, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 6, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 6, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 19, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 18, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 18, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 18, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 20, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 16, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 16, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 16, 2022 CNSL
EXAMINER'S AMENDMENT ENTERED
May 11, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 11, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2022 CRFA
ASSIGNED TO LIE
Jan 11, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 7, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 4, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2020 DOCK
ASSIGNED TO EXAMINER
Oct 19, 2020 DOCK
ASSIGNED TO EXAMINER
Oct 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2020 NWOS
NEW APPLICATION ENTERED
Jul 13, 2020 NWAP